Dexcom Reports Second Quarter 2020 Financial Results

Go back to Dexcom Reports Second Quarter 2020 Financial Results

DexCom (DXCM) Tops Q2 EPS by 44c, Revenues Beat; Offers FY20 Revenue Outlook

July 28, 2020 4:06 PM EDT

DexCom (NASDAQ: DXCM) reported Q2 EPS of $0.79, $0.44 better than the analyst estimate of $0.35. Revenue for the quarter came in at $451.8 million versus the consensus estimate of $415.74 million.

Second Quarter 2020 Financial Highlights:

Revenue grew 34% versus the same quarter of the prior year to $451.8 millionU.S. revenue growth of 38% and international revenue growth of 21%GAAP operating income of $67.8 million or 15.0% of revenue, an increase of 1520 basis points... More